Search results for: Primary care

Information on New Drug Approvals and Medication Safety

Michele B. Kaufman, PharmD, BCGP | March 8, 2012

Rheumatology-related drug safety, approvals, and what’s in the pipeline.

Unexpected Benefits of Bisphosphonates after Hip Fracture

Cathleen Colon-Emeric, MD, MHS | February 3, 2012

Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.

Time Is Important Factor in E/M Coding

Staff | February 3, 2012

It is not unusual for rheumatologists to spend significant time during an office visit reviewing new and/or existing problems, modifying medications, counseling, and coordinating care, but is this additional time reimbursable?

A&R and AC&R Abstracts: Bisphosphonates

Staff | February 3, 2012

Want to learn more about bisphosphonates and fractures? Check out these abstracts from Arthritis & Rheumatism and Arthritis Care & Research.

Shortcomings and Promises of Genome-wide Association Studies

Ann Kepler | February 3, 2012

The outcomes of genome-wide association studies (GWAS) have not been what scientists expected, but researchers are developing new approaches to use revelatory GWAS information to identify genetic causal variants, predictors of treatment response, and future opportunities for genetic insight.

Antiphospholipid Antibody Testing Update

Staff | January 13, 2012

Successes, challenges, and controversies of diagnostic methods for APS

Quality Measurement Improves Rheumatology Outcomes

Kathleen Louden | January 13, 2012

Innovations in health information technology can have significant impact

Drug Updates: Apremilast, Belimumab, and More

Michele B. Kaufman, PharmD, BCGP | January 13, 2012

Information on new approvals and medication safety

Data Rich, Information Poor

Staff | December 12, 2011

Did you know that the health information stored by your practice could be one of your most valuable assets?

Planning the ACR/ARHP Annual Scientific Meeting

Joel A. Block, MD | December 12, 2011

As the 2011 ACR/ARHP Annual Scientific Meeting ends, those of us on the Annual Meeting Planning Committee (AMPC) take time to reflect on the process and on the product.